Risk Factors for Central Lymph Node Metastasis of Patients with Papillary Thyroid Microcarcinoma: a Meta-analysis

Overview

Journal Int J Clin Exp Pathol

Specialty Pathology

Date 2014 Apr 4

PMID 24696711

Citations 42

Authors

Zeming Liu

Longqiang Wang

Pengfei Yi

Cong-Yi Wang

Tao Huang

Affiliations

Soon will be listed here.

Abstract

Objective: To evaluate the risk factors of central lymph node metastasis of papillary thyroid microcarcinoma.

Method: Published articles about papillary thyroid microcarcinoma were searched in PubMed, MEDLINE and EMBASE until October 2013 to examine the risky factors of central lymph node metastasis. Software RevMan 5.0 was used for meta-analysis.

Results: Within the patients suffering papillary thyroid microcarcinoma underwent thyroidectomy plus prophylactic central lymph node dissection, tumor size, multifocality and capsular invasion have statistically relevant association with central lymph node metastasis, but no relation was observed associated with sex and age.

Conclusion: The papillary thyroid microcarcinoma should be considered central lymph node metastasis when tumor size ≥0.5 cm, multifocality and have capsular invasion.

Citing Articles

Predictive Values of Clinical Features and Multimodal Ultrasound for Central Lymph Node Metastases in Papillary Thyroid Carcinoma.

Fu J, Liu J, Wang Z, Qian L Diagnostics (Basel). 2024; 14(16).

PMID: 39202260 PMC: 11353660. DOI: 10.3390/diagnostics14161770.

Risk stratification for central lymph node metastasis in mono-focal papillary thyroid carcinoma patients with encapsulated tumor as confirmed by preoperative ultrasound: a multi-center analysis.

Ji Y, Heng Y, Wang Z, Cai W, Wu C, Yang Z Endocrine. 2024; 86(3):1045-1054.

PMID: 39052200 DOI: 10.1007/s12020-024-03861-w.

Predictors of lateral lymph node metastasis and skip metastasis in patients with papillary thyroid microcarcinoma.

Yoon J, Park J, Hong A, Kim H, Kang H Front Endocrinol (Lausanne). 2024; 15:1392247.

PMID: 39015180 PMC: 11250241. DOI: 10.3389/fendo.2024.1392247.

The Underestimated Impact of Hashimoto Thyroiditis on Thyroid Papillary Carcinoma.

Harmantepe A, Ozdemir K, Bayhan Z, Kocer B Updates Surg. 2024; 76(3):1085-1089.

PMID: 38687448 PMC: 11130058. DOI: 10.1007/s13304-024-01854-y.

Effects of Patient and Tumor Characteristics on Central Lymph Node Metastasis in Papillary Thyroid Cancer: A Guide for Selective Node Dissection.

Altiner S, Kozan R, Emral A, Taneri F, Karamercan A Arch Iran Med. 2023; 25(11):730-736.

PMID: 37543897 PMC: 10685851. DOI: 10.34172/aim.2022.115.

References

Pellegriti G, Scollo C, Lumera G, Regalbuto C, Vigneri R, Belfiore A . Clinical behavior and outcome of papillary thyroid cancers smaller than 1.5 cm in diameter: study of 299 cases. J Clin Endocrinol Metab. 2004; 89(8):3713-20. DOI: 10.1210/jc.2003-031982. View

Bonnet S, Hartl D, Leboulleux S, Baudin E, Lumbroso J, Al Ghuzlan A . Prophylactic lymph node dissection for papillary thyroid cancer less than 2 cm: implications for radioiodine treatment. J Clin Endocrinol Metab. 2009; 94(4):1162-7. DOI: 10.1210/jc.2008-1931. View

Lim Y, Choi E, Yoon Y, Kim E, Koo B . Central lymph node metastases in unilateral papillary thyroid microcarcinoma. Br J Surg. 2009; 96(3):253-7. DOI: 10.1002/bjs.6484. View

Wang Y, Ji Q, Huang C, Zhu Y, Zhang L . [Predictive factors for level VI lymph node metastasis in papillary thyroid microcarcinoma]. Zhonghua Wai Ke Za Zhi. 2009; 46(24):1899-901. View

Shao Y, Cai X, Gao L, Li H, Xie L . [Clinical factors related to central compartment lymph node metastasis in papillary thyroid microcarcinoma: clinical analysis of 117 cases]. Zhonghua Yi Xue Za Zhi. 2009; 89(6):403-5. View

Tisell L, Nilsson B, Molne J, Hansson G, Fjalling M, Jansson S . Improved survival of patients with papillary thyroid cancer after surgical microdissection. World J Surg. 1996; 20(7):854-9. DOI: 10.1007/s002689900130. View

Sugitani I, Fujimoto Y . Symptomatic versus asymptomatic papillary thyroid microcarcinoma: a retrospective analysis of surgical outcome and prognostic factors. Endocr J. 1999; 46(1):209-16. DOI: 10.1507/endocrj.46.209. View

Wada N, Duh Q, Sugino K, Iwasaki H, Kameyama K, Mimura T . Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann Surg. 2003; 237(3):399-407. PMC: 1514312. DOI: 10.1097/01.SLA.0000055273.58908.19. View

Kutler D, Crummey A, Kuhel W . Routine central compartment lymph node dissection for patients with papillary thyroid carcinoma. Head Neck. 2011; 34(2):260-3. DOI: 10.1002/hed.21728. View

10.

Xiang J, Wu Y, Li D, Shen Q, Wang Z, Sun T . New clinical features of thyroid cancer in eastern China. J Visc Surg. 2010; 147(1):e53-6. DOI: 10.1016/j.jviscsurg.2010.02.007. View

11.

Lin J . Increased incidence of papillary thyroid microcarcinoma with decreased tumor size of thyroid cancer. Med Oncol. 2009; 27(2):510-8. DOI: 10.1007/s12032-009-9242-8. View

12.

Nam-Goong I, Kim H, Gong G, Lee H, Hong S, Kim W . Ultrasonography-guided fine-needle aspiration of thyroid incidentaloma: correlation with pathological findings. Clin Endocrinol (Oxf). 2003; 60(1):21-8. DOI: 10.1046/j.1365-2265.2003.01912.x. View

13.

Sobin L . Histological typing of thyroid tumours. Histopathology. 1990; 16(5):513. DOI: 10.1111/j.1365-2559.1990.tb01559.x. View

14.

Kim K, Kim E, Yoon J, Han K, Moon H, Kwak J . Preoperative prediction of central lymph node metastasis in thyroid papillary microcarcinoma using clinicopathologic and sonographic features. World J Surg. 2012; 37(2):385-91. DOI: 10.1007/s00268-012-1826-3. View

15.

Garrel R, Tripodi C, Cartier C, Makeieff M, Crampette L, Guerrier B . Cervical lymphadenopathies signaling thyroid microcarcinoma. Case study and review of the literature. Eur Ann Otorhinolaryngol Head Neck Dis. 2011; 128(3):115-9. DOI: 10.1016/j.anorl.2010.11.007. View

16.

Shattuck T, Westra W, Ladenson P, Arnold A . Independent clonal origins of distinct tumor foci in multifocal papillary thyroid carcinoma. N Engl J Med. 2005; 352(23):2406-12. DOI: 10.1056/NEJMoa044190. View

17.

Chen A, Jemal A, Ward E . Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer. 2009; 115(16):3801-7. DOI: 10.1002/cncr.24416. View

18.

Vergez S, Sarini J, Percodani J, Serrano E, Caron P . Lymph node management in clinically node-negative patients with papillary thyroid carcinoma. Eur J Surg Oncol. 2010; 36(8):777-82. DOI: 10.1016/j.ejso.2010.06.015. View

19.

Hay I, Hutchinson M, Gonzalez-Losada T, McIver B, Reinalda M, Grant C . Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period. Surgery. 2008; 144(6):980-7. DOI: 10.1016/j.surg.2008.08.035. View

20.

Giordano D, Gradoni P, Oretti G, Molina E, Ferri T . Treatment and prognostic factors of papillary thyroid microcarcinoma. Clin Otolaryngol. 2010; 35(2):118-24. DOI: 10.1111/j.1749-4486.2010.02085.x. View